XML 21 R5.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Balance Sheets - USD ($)
shares in Millions, $ in Millions
Dec. 31, 2022
Dec. 31, 2021
Current assets:    
Cash and cash equivalents $ 4,006 $ 4,438
Investments 3,499 3,202
Receivables 2,302 2,177
Prepaid expenses and other current assets 277 247
Total current assets 10,084 10,064
Property, equipment, and capitalized software, net 259 396
Goodwill and intangible assets, net 1,390 1,252
Restricted investments 238 212
Deferred income taxes 220 106
Other assets 123 179
Total assets 12,314 12,209
Current liabilities:    
Medical claims and benefits payable 3,528 3,363
Amounts due government agencies 2,079 2,472
Accounts payable, accrued liabilities and other 889 842
Deferred revenue 359 370
Total current liabilities 6,855 7,047
Long-term debt 2,176 2,173
Finance lease liabilities 215 219
Other long-term liabilities 104 140
Total liabilities 9,350 9,579
Stockholders’ equity:    
Common stock, $0.001 par value per share; 150 million shares authorized; outstanding: 58 million shares at each of December 31, 2022, and December 31, 2021 0 0
Preferred stock, $0.001 par value per share; 20 million shares authorized, no shares issued and outstanding 0 0
Additional paid-in capital 328 236
Accumulated other comprehensive loss (160) (5)
Retained earnings 2,796 2,399
Total stockholders’ equity 2,964 2,630
Total liabilities and stockholders’ equity $ 12,314 $ 12,209
Common Stock, Shares, Outstanding 58 58